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ABSTRACT Severe and persistent bacterial lung infections characterize cystic fibrosis (CF). While several studies have docu-
mented the microbial diversity within CF lungmucus, we knowmuch less about the inorganic chemistry that constrains micro-
bial metabolic processes and their distribution.We hypothesized that sputum is chemically heterogeneous both within and be-
tween patients. To test this, we measured microprofiles of oxygen and sulfide concentrations as well as pH and oxidation-
reduction potentials in 48 sputum samples from 22 pediatric patients with CF. Inorganic ions were measured in 20 samples from
12 patients. In all cases, oxygen was depleted within the first fewmillimeters below the sputum-air interface. Apart from this
steep oxycline, anoxia dominated the sputum environment. Different sputum samples exhibited a broad range of redox condi-
tions, with either oxidizing (16 mV to 355 mV) or reducing (300 to107 mV) potentials. The majority of reduced samples con-
tained hydrogen sulfide and had a low pH (2.9 to 6.5). Sulfide concentrations increased at a rate of 0.30MH2S/min. Nitrous
oxide was detected in only one sample that also contained sulfide. Microenvironmental variability was observed both within a
single patient over time and between patients. Modeling oxygen dynamics within CFmucus plugs indicates that anoxic zones
vary as a function of bacterial load andmucus thickness and can occupy a significant portion of the mucus volume. Thus, aerobic
respiration accounts only partially for pathogen survival in CF sputum, motivating research to identify mechanisms of survival
under conditions that span fluctuating redox states, including sulfidic environments.
IMPORTANCE Microbial infections are the major cause of morbidity andmortality in people living with CF, and yet microbial
growth and survival in CF airways are not well understood. Insufficient information about the chemistry of the in vivo environ-
ment contributes to this knowledge gap. Our documentation of variable redox states corresponding to the presence or absence of
sulfide begins to fill this void andmotivates understanding of how different opportunistic pathogens adapt in these dynamic
environments. Given the changing chemical state of CF sputum over time, it is important to consider a spectrum of aerobic and
anaerobic lifestyles when studying CF pathogens in the laboratory. This work not only provides relevant constraints that can
shape the design of laboratory experiments, it also suggests that sulfide might be a useful proxy for assessing the redox state of
sputum in the clinic.
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Cystic fibrosis (CF) is an autosomal recessive human geneticdisease resulting from mutations in the cystic fibrosis trans-
membrane conductance regulator (CFTR) gene (1). Mutations in
the CFTR gene result in the defective transfer of ions across mem-
branes, impacting many body systems, but most severely the re-
spiratory tract. The loss of ion homeostasis at the respiratory epi-
thelium leads to the presence of a dehydrated, thickened mucosal
layer that accumulates and can obstruct the airways as well as limit
the motion of the airway cilia. People living with CF are suscepti-
ble to chronic lung infection by opportunistic pathogens because
of their inability to clear thickened mucus from airways (2, 3).
These infections ultimately are responsible for their morbidity
and mortality (4–6). CF has been characterized in 70,000 individ-
uals worldwide, with 30,000 residing in the United States and ap-
proximately 1,000 new cases of CF diagnosed each year. The pop-
ulation of people living with CF is split nearly evenly between
adults and pediatric patients, emphasizing the importance of pe-
diatric CF research (7). CF is characterized by the accumulation of
irreversible lung damage,motivating early intervention to prevent
disease progression.
The diversity and adaptation of opportunistic pathogens
within the CF lung environment are, in part, what render CF in-
fections so difficult to eradicate (8–10). Yet a growing body of
research on the stability of microbes in different ecosystems, such
as the human gut, indicates that, while diversity at the organismal
level can be vast, the metabolic networks that underpin microbial
communities are often conserved and constrained by environ-
mental parameters (11). Few studies have attempted to character-
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ize the in vivo chemistry of mucus collecting in CF airways, yet
such measurements are essential if we are to understand how mi-
croorganisms survive in the lung and impact the microenviron-
ment. Oxygen is a key inorganic substrate whose abundance dic-
tates which metabolisms are utilized. To date, three studies have
directly measured the oxygen content in people living with CF.
Oxygen measurements completed during bronchoscopies of up-
per lung lobes of three CF patients demonstrated oxygen deple-
tion in mucopurulent masses (12). Oxygen profiles of 20 CF pa-
tients undergoing sinus surgery revealed lower oxygen tension in
the mucosa of the sinus, but not the sinus lumen; anoxic condi-
tions were found in 18% of the measured CF sinuses (13). Re-
cently, N2O and O2 concentrations were profiled in sputum sam-
ples from7CF patients; these samples were collected in cylindrical
glass vials. Under these sampling conditions, an oxygen gradient
near the air-sputum interface was followed by an anoxic zone, in
which N2O accumulated and disappeared over time (14). Amino
acids, sugars, salts, phenazines, and iron oxidation states have also
been quantified in bulk sputum samples (15–17). Other chemical
parameters, including the pH of exhaled breath, have been mea-
sured directly from patients (18, 19).
Studies measuring gene expression have shed complementary
light on microbial adaptation to environmental changes. While
important members of the CF lung community, such as Pseu-
domonas aeruginosa, are sometimes still referred to as “obligate
aerobes” (20, 21), it is generally well accepted that they have the
capability for microaerobic growth in 3 to 10 MO2 (22), as well
as for anaerobic growth and survival (16, 21, 23–28). Moreover,
several studies have found evidence for the presence of strict an-
aerobes within CF microbial populations, through both culture-
dependent and culture-independent approaches (29, 30). Indeed,
a recentmetagenomic andmetatranscriptomic study ofmicrobial
communities in 6 different patients revealed that CF lung patho-
gens utilize a variety of anabolic and catabolic pathways. For ex-
ample, CF lung communities expressed enzymes involved in
amino acid catabolism, folate biosynthesis, and lipoic acid biosyn-
thesis. In addition to energy generation via fermentative path-
ways, the data were consistent with catabolism by oxidative phos-
phorylation using a variety of terminal electron acceptors (31).
Despite appreciation of the metabolic versatility of many CF
pathogens, relatively little is known about the variability in redox
states between andwithin patients at themicroscale and the extent
to which organisms within the sputum environment would be
expected to adapt to changes in the oxygen tension. To gain more
insight into these aspects, we must consider the physical con-
straints of the lung. Figure 1 provides an overview of the respira-
FIG 1 Overview of the respiratory airways. Tan coloring indicates mucus. Cyan dashed arrows indicate the direction of possible oxygen transport. In CF lungs,
mucus can aggregate in different scenarios. In each scenario, “d” indicates the diameter of the airway and “x” indicates the mucus thickness. (A) Although less
common in CF, the small airways, the alveolar sacs, can clog with mucus entirely (d 200 m). (B) The surface layer of the bronchioles becomes dehydrated,
andmucus thickening begins (300m d 1,000m). (C)Mucus aggregates can dislodge from lower airways and become lodged in larger, upper airways (the
d value depends on the airway the aggregate is dislodged into; 300 m d 5,000 m).
Cowley et al.
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tory airways starting from the trachea and branching downward
into the smallest respiratory airways, the alveoli. The airway sur-
face layer becomes dehydrated and viscous in CF patients. The
ciliated epithelium is unable to clear the thickenedmucus bymov-
ing it to larger airways, leading to obstructed airways and complete
blockages. Early lung disease is observed initially in the bronchi-
oles, alveolar sacs, and alveoli, as they are most easily blocked by
mucus aggregation. We illustrate three possible deleterious sce-
narios: an entire airway can become blocked, although this is less
common in CF (Fig. 1A); airway surface layers can thicken, result-
ing in restricted airflow (Fig. 1B); and, finally, a mucus plug can
become dislodged andmove into a larger airway (Fig. 1C). Expec-
torated sputum can have diverse airway sources. Expectoration
clears the airways only temporarily, and exacerbation itself can
cause larger volumes of sputum to be produced; patients with
greater disease severity generally produce more sputum.
Ultimately, the electron accepters and the nutrients available in
dynamic environments such as CF sputum dictate which micro-
bial metabolisms will be possible. In turn, microbial depletion of
oxygen and nutrients, as well as the generation and accumulation
of metabolic products, can modify local chemistry and provide
information on microbial activities. This predicts a dynamic spu-
tum microenvironment with metabolically versatile microbial
communities that adapt to or evolve with changing chemical pa-
rameters. In this study, we sought to characterize the CF sputum
environment at the microscale through direct measurements of
samples fromdifferent patients over extended time periods. Using
modeling, we constrain how these measurements map to geome-
tries of relevance within CF airways.
RESULTS
Apart from a thin oxic surface layer, all sputum samples are
anoxic. As a first step toward constraining the in vivo environ-
ment, we used oxygen microsensors to profile freshly expecto-
rated sputum (see Materials andMethods). A total of 48 different
sputum samples from 22 different pediatric patients living with
CF were profiled for oxygen, and all measurements were per-
formed within 15 min of expectoration. This time period was the
shortest allowed by sample processing constraints. Control exper-
iments were performed to determine whether the time elapsed
after expectoration affected the oxygen concentrations. Oxygen
profiles measured in the same sputum sample at different starting
positions and different time intervals, from 6 min to 4 h after
collection, demonstrated similar patterns with very little variation
over time in oxygen penetration depth (see Fig. S1 in the supple-
mentalmaterial). This likely reflects a steady state between oxygen
diffusion into the sputum sample and consumption. As previously
seen (14), we observed a characteristic oxygen profile using a
Clark-type amperometric microelectrode (detection limit of
0.30 M), consisting of a steep oxycline at the top of the air-
sputum interface leading to an anoxic zone (0 M O2), for all
samples. Effectively zero O2 availability in the anoxic zone was
confirmed by using an amperometric switchable trace oxygen
(STOX) sensor (32), which can detect ultralow (as low as 2 nM)
oxygen concentrations (Fig. 2A). Six samples were profiled with
the STOX sensor, 3 of which were also profiled with the stan-
dard O2 microelectrode. Since negligible O2 levels were de-
tected in all STOX electrode profiles, all subsequent profiles
were profiled with the standard O2 sensor only. Figure 2B dis-
plays the oxycline leading to anoxia for 5 of the smaller samples
by volume (1,000 mm3), while Fig. 2C displays the oxycline
and subsequent anoxic zone for 5 of the samples with larger
volumes (1,000 mm3). The average volumetric fraction of all
samples containing detectable oxygen was ~30% (n  20).
Sputum redox profiles exhibit spatiotemporal variability.
Having established that anoxia characterizes the main volume of
all expectorated sputum samples, we measured the oxidation-
reduction potential (ORP) by profiling 28 samples with a redox
microelectrode in tandem with the oxygen sensor. As shown in
Fig. 3, the ORP profiles could be separated into two groups: one
comprising 17 samples with a positive redox potential range
(16 mV to 355 mV), representing an oxidized, albeit anoxic,
microenvironment (Fig. 3A), and another comprising 11 samples
displaying a negative redox potential range (300 mV to
107 mV), indicating a reducing microenvironment (Fig. 3B).
Four patients profiled on multiple days showed different redox
states at different times (see Table S1 in the supplemental mate-
rial).
Reduced sputum samples show an accumulation of hydro-
gen sulfide. To identify a possible redox couple setting the poten-
tial of highly reduced samples, we added an amperometric hydro-
gen sulfide (H2S) sensor (33), mindful that a low redox potential
may be caused by the presence of reduced sulfur compounds.
Twenty-three sputum samples from 17 patients were profiled
simultaneously using one O2, one redox, and one H2S micro-
sensor. Sixteen samples grouped into the more oxidized ORP
class (ORP  0 mV), and H2S was detected in 1 of those sam-
ples (Fig. 4A). Seven of the samples fell into the more reduced
class (ORP  0 mV), and H2S was detected in 5 of those sam-
ples (Fig. 4B). We also measured pH profiles of the sputum
samples with detectable H2S, in parallel to the H2S profiles,
revealing a pH range of 2.9 to 6.5 (see Table S2 in the supple-
mental material). Additionally, we profiled 4 samples without
detectable H2S with the pH sensor, finding 3 to be acidic and 1
basic (see Table S2). Intriguingly, 4 individuals presented sul-
fidogenic sputum on some occasions but not all.
All H2S microprofiles were recalculated and displayed as to-
tal sulfide concentrations using the corresponding pH values
(H2S [H2S] [HS] [S2]); here, we use the term “sulfide”
to represent all of those species (33, 34). The pH values were stable
during the course of profiling, even over several hours. The total
sulfide concentration values likely represent conservative esti-
mates because they reflect only what is in the aqueous phase; given
that ferrous iron levels in sputum can be high (17), it is possible
that in some of our samples the presence of poorly solublemineral
phases, such as FeS, may have lowered the amount of detectable
sulfide. To determine the rate of sulfide accumulation, we mea-
sured sulfide concentration profiles over time. An example of
temporal sulfide accumulation is shown in Fig. 5A. In 5 of the 6
sulfidic samples, we couldmeasure sulfide accumulation, with 4 of
those shown in Fig. 5B. Sulfide concentrations increased at an
average rate of 0.30 0.25M/min (n 5). Sulfide depletionwas
not observed in these samples over the course of measurement.
The sulfidic samples and nonsulfidic samples were profiled on the
same time scale; while the O2 profiles were stable regardless of
whether sulfide was detected, the fact that sulfide could accumu-
late over time in some samples indicates that they were not in the
steady state. Nevertheless, the 15-min gap between expectoration
and measurement is small enough to ensure that we captured in
vivo conditions in our initial profiles.
CF Sputum Is Chemically Dynamic and Can Be Sulﬁdic
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Inspired by the detection of N2O in sputum from adults (14,
35) and in an effort to identify other redox couples responsible for
theORPs observed, we profiled 4 of our pediatric sampleswithO2,
H2S, redox potential, andN2O sensors. Only one sample hadmea-
surable N2O, which accumulated in the anoxic zone but did so
above the layer where sulfide was detected (see Fig. S2A in the
supplemental material). The other 3 samples had no detectable
H2S or N2O (see Fig. S2B).
Ion concentrations in sputum are variable, but high [NH4]
correlates with reduced samples. To gain insight into the vari-
ability in redox states and the potential for sulfide accumulation,
we measured the inorganic ions present in sputum samples of
sufficient volume to collect a filtrate. The average ion concentra-
tions determined in randomized triplicate experiments in 21 spu-
tum samples from 12 different patients profiled with the micro-
electrode were as follows: for Cl, 21.77  14.92 (standard
deviation [SD]) mM; for NO3, 0.48  0.57; for SO42, 0.32 
0.23; for Na, 26.63  14.58; for NH4, 4.92  2.30; for K,
7.72  4.78; for Mg2, 0.49  0.32; and for Ca2, 1.32 
0.54.While large variations in ion concentrations were found, all re-
duced samples had higher concentrations of ammonium than the
oxidizedsamples,withconcentrations reachingashighas10mM(see
Table S3 in the supplemental material). However, there was no ap-
preciable difference in sputum sulfate concentrations between sul-
fidic samples (0.23 0.15 [SD]mMsulfate) andnonsulfidic samples
(0.33 0.23 [SD]mM sulfate) (see Table S3), suggesting that sulfate
reduction is unlikely to be the source of sputum sulfide. Taking pa-
tient 10, who had sulfidic and nonsulfidic samples, as an example,
there was statistically no change in sulfate concentrations between
samples, suggesting the absence of sulfate reduction.
Modeling predicts extensive sputum hypoxia and anoxia in
vivo. While chemical measurements of freshly expectorated
FIG 2 Representative oxygenmicroprofiles. (A) STOXmicroprofile, with the sputum samplemarked in tan, representative of n 8. The green rectangle shows
an expanded view of a portion of the anoxic zone in the sputum sample. The detection limit is 2 nM. (B) Oxygen microelectrode profiles of 5-mm-deep
expectorated sputum samples from 5 different patients, representative of n 12. At the air-sputum interface, a steep oxycline begins and is followed by an anoxic
zone that persists for the remaining portion of the sputum. (C) Oxygen microelectrode profiles of 8-mm-deep expectorated sputum samples from 5 different
patients that were larger in volume, representative of n 27. The same trend in profile occurs, with a steep oxycline followed by anoxia.
Cowley et al.
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sputum provide insight into the in vivomicroenvironment, the
geometry of our sampling vessels differs from that of the air-
ways. Short of making microsensor measurements during
bronchoscopies, which poses a variety of technical problems
and potential health risks to the patient, we can constrain the in
vivo relevance of our ex vivo microsensor profiles using models
whose parameters are informed by our experimental measure-
ments. Our model predicts sputum oxygen dynamics solely as a
function of microbial growth and aerobic respiration. We as-
sume inhaled air is the dominant source of oxygen for mucus.
For simplicity, we assume microbial cell density to be homog-
enous and we neglect host oxygen consumption (e.g., by im-
mune cells such as polymorphonuclear leukocytes [PMNs])
(36, 37), hemoglobin (Hb) in capillaries near the epithelium,
and oxygen scavenging by reductive metabolites generated
within sputum (e.g., sulfide). Creating a more complex model
accounting for host oxygen consumption and reductive metab-
olite scavenging would lead to steeper oxyclines and lower bac-
terial densities to account for the oxygen concentrations. Ac-
cordingly, our model is conservative and likely overestimates
oxygen content in vivo.
Within the airways, oxygen diffuses from the boundary
layer at the air-mucus interface into the mucus. We can model
mucus oxygen concentrations as a steady-state balance be-
tween oxygen diffusion and microbial respiration and as a
function of mucus layer thickness, microbial density, and var-
ious physical and physiological constraints. This approach is an
extension of a published model of oxygen diffusion into micro-
bial colonies balanced by respiration (38). Briefly, the model is
formalized as follows:
 [O2]
 t
 DO2 · 
2[O2] Q · a (1)
where oxygen [O2] (mol O2 · m3) diffuses with diffusivity DO2
(m2 · s1) depending on the local oxygen concentration gradient
and is consumed at rate Q (mol O2 · s1 · g cells1) by a respiring
O2 [µM] Redox [mV]
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FIG 3 Representative examples of high and low sputum ORPs. The tan-
shaded boxes indicate the extent of the sputum sample. (A)Of 23 of the redox-
profiled samples, 11 displayed a positive redox potential (16 mV to 355 mV)
indicative of an oxidizing microenvironment. (B) Of 23 of the profiled sam-
ples, 17 displayed a negative redox potential (300 mV to107 mV) indica-
tive of a reducing microenvironment.
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FIG 4 Representative examples of ORPs in tandem with H2S detection. The
tan-shaded boxes indicate the extent of the sputum sample. (A) A total of 14 of
the 16 sputum samples that were highly oxidized samples (positive reduction
potential) did not exhibit a presence of H2S. (B) A total of 5 of the 7 sputum
samples that were highly reduced (negative reduction potential) exhibited the
presence of H2S and were acidic.
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microbial community with density a (g cells · m3). Assuming O2
to be the limiting nutrient in the system, the oxygen consumption
rate Q can be expressed in terms of a Monod-type growth rate
saturation model and a maintenance term:
Q

YO2
 PO2
max
YO2
·
[O2]
kO2 [O2]
 PO2 (2)
with a maximum specific growth rate  max (s1), yield coef-
ficient YO2 (g cells
· mol O21), half-saturation constant kO2
(mol O2 · m3), and the maintenance oxygen requirement PO2
(mol O2 · s1 · g cells1).
At the steady state O2
t
 0, diffusion and respiration are
balanced and describe a stable oxygen profile whose shape de-
pends on the above-mentioned parameters as well as on con-
straints imposed by geometry-specific boundary conditions (see
Materials and Methods for details).
Three relevant geometries to consider in the context of CF lung
mucus aggregation are outlined in Fig. 1 (scenarios A, B, and C).
By keeping the physical parameters (oxygen diffusivity, mucus
thickness, etc.) and the physiological parameters (maximal
growth rate, oxygen half-saturation, etc.—see Materials and
Methods for details) constant but adjusting bacterial densities at
realistic values for CF mucus (39), we explored how the shape of
mucus in these different contexts might impact expected oxygen
gradients. Despite the limited (500-m) depth assumed for these
calculations, the model predicts a steep oxycline leading to exten-
sive anoxic zones at higher cell densities (Fig. 6), regardless of
geometry. For comparison, Table 1 lists the maximal depths of
oxygen penetration below which all mucus is anoxic for the two
geometric extremes (dislodged spherical aggregates and single air-
way plugs) over a range of cell densities. By fitting 32 expectorated
sputum oxygen microsensor profiles with our spherical mucus
aggregatemodel, we infer average cell densities of 8.3 107 cell/ml
for these sputum samples (see Table S4 in the supplemental ma-
terial), which is in line with direct bacterial counts from other
studies (39). Such fitting is justified because sputum itself is quite
hydrated and surrounded by saliva, so the limiting diffusivity is
always that of water. As indicated in Table 1, this suggested that,
on average, at these densities, anoxic zones would be expected in
clogged airways with mucus layer thickness greater than 1 mm.
The shape and thickness of the oxycline are also affected by all
other physical and physiological parameters (see Materials and
Methods and Table 2). Unlike cell density, however, most other
physical and physiological parameters are unlikely to change by
orders of magnitude. This reduces their potential effects on oxy-
cline scaling, with oxygen diffusivity likely the second most im-
pactful variable parameter. For comparison to Fig. 6, we illustrate
the potential effect of variable oxygen diffusivities with 3 different
literature estimates (for water, biofilm, and rat colon mucus) (see
Fig. S3 in the supplemental material). We used the intermediate
biofilm diffusivity value for all other modeling results.
Consideringmucus restrictions in the lung to begin by a thick-
ening of the normal airway surface layer, we modeled the two-
dimensional (2D) distribution of oxygen in bronchioles to illus-
trate the spatial distribution. As for the 1Dmodels shown in Fig. 6,
we adjusted the bacterial density from107 cells/ml to 1010 cells/ml;
in addition, for the 2Dmodels, we adjusted themucus layer thick-
ness from 50 to 400 m based on reported values (40–43). Fig-
ure 7A reveals that airways with a 50-m-thick layer of mucus
would be expected to never become anoxic for the cell densities
used in the model. In mucus layers that are 250 m thick, anoxic
conditions would be attainable only with very dense microbial
populations (~109 cells/ml). In 400-m-thick layers, however, an-
oxia could be reached at the epithelial cell boundary with popula-
tion densities as low as 108 cells/ml. A corollary to the oxygen
distributions modeled in Fig. 7A is that oxygen-dependent respi-
ratory growth rates would range from low to zero in many cases
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FIG 5 Sulfide can build up rapidly in sputum. (A) Dynamics of total sulfide
production over time in one sputum sample incubated for a total of 240 min.
Time increases from left to right (orange to pink). This is the same sample
represented by the purple line in panel B. The tan box indicates the depth of the
sputum sample. (B) Increases in sulfide levels over time in sputum samples
incubated at 37°C for 4 different patients. Each color represents a different
sputum sample profiled over time. Each time point represents the maximum
sulfide concentration for a specific profile. Not all of the maxima were re-
corded at the same depth in the samples. For the sample represented by the red
line, the average maximum sulfide depth was within the range of 6.85 to
7.40mm; for the green sample, 9.85 to 13.30mm; for the blue sample, 15.60 to
18.30 mm; and for the purple sample, 8.15 to 11.25 mm. Five of the sulfidic
samples were profiled over a period of up to 300 min and demonstrated a
significant increase in the sulfide level.
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(Fig. 7B). Again, we hasten to note that this simple model neglects
oxygen consumption by the host as well as abiotic oxidation by
reduced metabolites; thus, its predictions with respect to oxy-
gen abundance are conservative. Accordingly, it is probable
that hypoxia and anoxia dynamically occur in vivo and would
likely dominate the microenvironments in larger regions of the
airways even at relatively low cell densities (e.g., 107 cells/ml).
Collectively, these results reinforce the importance of consid-
ering mechanisms of adaptation to variable oxygen concentra-
tions within the CF lung.
Clinical data. Of the 48 samples profiled, 32 were also cul-
tured for dominant CF pathogens by the Children’s Hospital Los
Angeles (CHLA) clinical microbiology laboratory. As shown in
Table S1 in the supplemental material, 13 samples harbored
P. aeruginosa, 12 contained Staphylococcus aureus, 5 were positive
for both P. aeruginosa and S. aureus, and 2 had neither pathogen.
The presence of a specific organism did not significantly correlate
with the reduction potential state, pH, or presence of sulfide (see
Table S5 in the supplemental material). However, of the clinical
parameters reviewed (including age, sex, race, diagnosis of pan-
creatic insufficiency, cystic fibrosis-related diabetes, gastroesoph-
ageal diseases, CF liver disease, or allergic bronchopulmonary
Aspergillus infection, hemoglobin A1c [HbA1c] levels, IgE levels,
blood glucose levels, sputum iron levels, visit reason [inpatient or
outpatient], height, weight, body mass index [BMI], intravenous
[i.v.] antibiotic status, supplementary-oxygen status, pulmonary
exacerbation, antibiotic and othermedication, culturedmicrobes,
and spirometry results; see Tables S1 and S5) for the 23 samples
profiled for sulfide, the presence of sulfide was positively corre-
lated with reduced reduction potential (P 0.001), increased IgE
values, lack of supplemental oxygen, a decreased likelihood of the
subject being an inpatient, and larger sputum samples (P 0.05)
(see Table S5). Although we do not have enough patient samples
to support a statistically significant correlation at present, we note
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FIG 6 Comparison of levels of oxygen diffusion into mucus based on different respiratory airway geometry constraints and bacterial densities. Data represent
oxygen diffusion into different respiratory airways clogged withmucus at various bacterial densities. The described scenarios correspond to the diagram in Fig. 1
with a modeled mucus thickness (x) of 500 m and an airway diameter of 1.5 mm for scenario B (model scenarios A and C are not affected by the airway
diameter). The upper blue shaded area indicates air, and the tan lower layer indicates mucus.
TABLE 1 Modeled oxygen penetration depths (i.e., oxycline thickness)
for mucus-clogged airways and dislodged mucus aggregates with
various bacterial densitiesa
Density
(cells/ml)
Diffusion into dislodged
mucus aggregate
Diffusion into mucus-
clogged airway
1.00E05 39 mm 28 mm
8.10E05 14 mm 9.7 mm
1.00E06 12 mm 8.8 mm
1.00E07 3.9 mm 2.8 mm
8.30E07 1.3 mm 960m
1.00E08 1.2 mm 880 m
1.00E09 390 m 280 m
1.30E09 340 m 240 m
1.00E10 120 m 88 m
1.00E11 39 m 28 m
1.00E12 12 m 8.8 m
a The data in the row in boldface type closely match the average profiles from our
experimental data.
TABLE 2 Modeling constants
Constant Value Unit(s)
Oxygen diffusion coefficient in
water (86)
26.8 106 cm2·s1
Oxygen diffusion coefficient in
biofilm (86)
15.3 106 cm2·s1
Oxygen diffusion coefficient in rat
colon mucus (87)
2.4 106 cm2·s1
Oxygen half-saturation constant (38) 0.0124 Mol O2 m3
Maximal growth rate (38) 0.00023 s1
Growth yield (88) 20.32 g·cell/mol O2
Maintenance coefficient for O2 (38) 1.22 107 mol O2 g cell1 s1
Cell density (39) 9.1 Log (cells / ml)
Cell weight (38) 2.14 1012 g/cell
Oxygen at air-mucus boundary (79) 209.3 M
CF Sputum Is Chemically Dynamic and Can Be Sulﬁdic
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that reduced samples and the presence of sulfide were found in
sputum from patients with mild to moderate lung function im-
pairment but not in those who were severely impaired (see Ta-
ble S1).
For the 30 samples profiled for reduction potential, an oxidized
environment significantly correlates with cystic fibrosis-related
diabetes (CFRD) (P 0.01), a lack of sulfide (P 0.01), and the
presence ofmethicillin-sensitive S. aureus (P 0.05) (see Table S5
in the supplemental material).
DISCUSSION
In this study, we measured sputum inorganic chemistry in a large
pediatric cohort of children living with CF from Children’s Hos-
pital Los Angeles (CHLA). By using a suite ofmicroelectrodes and
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FIG 7 Predicted oxygen concentrations and generation times due to aerobic respiration in bronchioles clogged with mucus. (A) Differential oxygen concen-
trations affecting the thickness of the mucus and the bacterial density. (B) A two-dimensional visualization of the bronchiole with variation in the mucus
thickness and bacterial density and the resulting predicted generation time of the pathogens in themucus during growth only via aerobic respiration (resp.). This
accounts only for aerobic respiration and neglects other catabolic pathways.
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making multiple measurements of sputum from individual pa-
tients, we were able to determine the extent of chemical variability
both within and between patients. In all samples, oxygen was de-
pleted rapidly within a narrow oxycline, rendering themajority of
the sputum anoxic. Moreover, the anoxic regions presented a
strikingly large range of oxidation-reduction potentials that were
both spatially and temporally variable; the lowest redox potentials
measured (300 mV) appear to have been caused by production
and accumulation of sulfide. Even at different spatial scales within
the lung, anoxia would be expected to constitute a significant frac-
tion of the in vivo sputum environment. These results are directly
relevant with respect to informing laboratory studies for elucida-
tion of mechanisms of microbial adaptation and survival within
CF lung infections.
Oxygen availability is one of the most critical inorganic pa-
rameters that determine microbial activity (44). Ironically, de-
spite the fact that infections take hold in the lung, the site of
oxygen intake to the body, the results of our studies demon-
strate that the mucus microenvironment rapidly becomes an-
oxic and even reduced in the presence of sulfide. Two other
studies have previously shown that the sputum microenviron-
ment contains hypoxic and anoxic zones (12, 14). Yet one may
question whether the oxygen sensors used in those studies were
sufficiently sensitive to detect the low levels of oxygen that can
sustain microbial growth. This concern is partially allayed by
our profiles utilizing the ultrasensitive STOX system, which
had a detection limit of 2 nM. While the minimum oxygen
requirement for aerobic respiration by most CF pathogens is
unknown, Escherichia coli can respire down to levels of3 nM
(45). While it is reasonable to expect that appreciable hypoxic
zones occur in vivo, our modeling studies strongly suggest that
the extent of hypoxia versus anoxia depends on the local geom-
etry and microbial density. It is therefore most probable that
CF sputum is spatially heterogeneous, spanning oxygen-
replete layers located just at and below the air-sputum inter-
face, hypoxic zones within a thin oxycline, and entirely anoxic
microenvironments that may dominate the majority of the
sputum below the oxycline. We underscore that our model is
conservative, ignoring host oxygen consumption and reductive
metabolite (e.g., sulfide) scavenging. A previous study demon-
strated that oxygen consumption by host immune cells, PMNs,
is likely the major oxygen sink within sputum, suggesting that
even steeper oxyclines than those predicted by our model and
lower bacterial densities are required to account for the oxygen
concentrations (36). Growth using oxygen becomes diffusion
limited based on our modeling and experimental measure-
ments, suggesting that microbes need to shift to anaerobic me-
tabolisms or enter a no-growth survival state.
While this conclusion is not surprising given the extensive
documentation of oxygen limitation in other stratified micro-
bial habitats (46–50), the large range of reduction potentials
measured in different anoxic sputum samples was unexpected.
Moreover, that these different redox states can exist not only
between different patients but also at different times within the
same patient highlights the dynamic character of the sputum
microenvironment—something that is not typically consid-
ered. Intriguingly, in most cases (20 of 23), the presence or
absence of sulfide correlated with highly reduced reduction
potentials. Because many oxidized and reduced sulfur redox
pairs have low redox potentials (51), it seems likely that re-
duced sulfur species were controlling the reduction potentials
measured in these samples and that their pH levels were uni-
formly low. This suggests that monitoring breath sulfide may
afford a means to assess the redox state within a patient’s lungs;
detecting hydrogen sulfide in the breath is not unprecedented
(52–54). That total sulfide can accumulate in some samples at a
rate of 0.30 M/min demonstrates the considerable potential
for sulfide production in vivo; however, sulfide would not be
expected to accumulate in vivo to the levels measured unless it
were generated in mucus plugs greater than 1 mm in thickness
when the microbial load is ~8  107 cells/ml. It is noteworthy
that we did not detect sulfide in every reduced sample, suggest-
ing that other metabolites with low redox potentials must con-
tribute to setting the redox state in some cases or that the sul-
fide is not available for detection with the sensors. In the three
cases with low reduction potentials and yet undetectable sul-
fide, organic metabolites, such as phenazines—which are
known to be generated in sputum and have a broad range of
reduction potentials (16, 55)—might instead help set the redox
potential. Regardless, samples with reduced reduction poten-
tials had a higher concentration of ammonium, potentially in-
dicating a fermentative source of ammonium (31); even lower
potentials could correspond to acetogenesis (56).
We do not yet know whether sulfide generated in vivo origi-
nates from a microbial or human source. Of relevance to the for-
mer, our major ion analysis for 6 patients and 6 samples indicates
that sulfate is present at 0.23  0.15 (SD) mM. Though sulfate-
respiring bacteria (SRBs) could in principle be a source of sputum
sulfide (possibly entering from the gut [57]), neitherwe nor others
have found evidence for their presence (31, 58–60). Sulfide could
also be a byproduct of amino acid degradation mediated by the
microbial community (61–64). It is perhaps more likely that sul-
fide is being generated from arginine, cysteine, and homocysteine
as a defense mechanism against oxidative stress, as has been dem-
onstrated to occur for S. aureus and P. aeruginosa in laboratory
experiments (65). Disentangling these possibilities awaits future
research.
Taking our environmental measurements into consideration,
we can speculate on how particular chemical variables might im-
pact themetabolic strategies ofmembers of theCFmicrobial com-
munity. Extensive hypoxia and anoxia would favor organisms ad-
ept at generating energy in the absence of oxygen. Consistent with
this prediction, the major CF pathogens, including P. aeruginosa,
S. aureus, Burkholderia cepacia, Stenotrophomonas maltophilia,
Haemophilus influenzae, Klebsiella pneumoniae, Escherichia coli,
Achromobacter xylosoxidans, and Aspergillus fumigatus, are all ca-
pable of aerobic and anaerobic metabolisms. Table 3 lists repre-
sentative anaerobic metabolisms (both respiratory and fermenta-
tive) that previous studies have identified as being relevant in the
CF lung, ranked in order from greatest- to least-energy-yielding
capacity under standard conditions using lactate as a carbon
source (15, 66, 67). Assuming the presence of chemical species
that would dominate at neutral pH, we can predict whether these
metabolisms would be thermodynamically favored or inhibited
by lowering pH. The acidic pHmeasured in many of our samples
would favor aerobic respiration, denitrification, sulfate reduction,
fumarate reduction, and acetoclasticmethanogenesis. In contrast,
basic pH would favor acetogenesis. Altering the pH would not be
expected to affect hydrogenotrophic methanogenesis. We note
that these predictions do not take into consideration the actual in
CF Sputum Is Chemically Dynamic and Can Be Sulﬁdic
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vivo concentrations of all the relevant chemical species that would
be necessary to estimate the true thermodynamic favorability of
any particularmetabolism and also do not consider kinetic effects.
However, in general, it is reasonable to conclude that the low-pH
regimens observed inmany of our samples are consistent with the
thermodynamic progression of several important types of anaer-
obic metabolisms.
Beyond impacting energy generation pathways, the chemical
parameters we have measured would be expected to affect the
microbial community in other ways. For example, it is known that
for S. aureus—one of the dominant culturable organisms in our
patients—low or high pH inhibits growth and/or biofilm forma-
tion (55–57). At low pH, S. aureus upregulates virulence genes,
including several that are also upregulated in response to antibi-
otics (68, 92); consistent with this response, S. aureus is more
resistant to aminoglycoside drugs at low pH (69). Similar pH ef-
fects on virulence gene expression and antibiotic resistance have
been found for other pathogens as well (70).
How might sulfide affect microbial or host cell activities? One
means could be to block particular enzymatic activities. Intrigu-
ingly, in the one sample where we measured N2O levels, the re-
duction potential was highly positive where N2O was present, as
expected for an anoxic zone dominated by denitrification (51),
and yet the potential decreased in the portion of the sample where
sulfide was detected. N2O is primarily an intermediate in nitrifi-
cation or denitrification processes, requiring oxygen or nitrate,
respectively, whichmight explain its occurrence in the upper por-
tion of the sputum. Because sulfide can inhibit nitrous oxide re-
ductase, which catalyzes the conversion ofN2O toN2, the presence
of sulfide could explain the accumulation of N2O in this sample.
The consequence of such an inhibitory effect would be metabolic
stratification to different sputum zones. It is also possible that
sulfide generation would alter the bioavailability of ferrous iron,
which is typically found in concentrations of 10mM to 100mM in
sputum (17), through precipitating ferrous sulfide minerals (51).
Finally, sulfide would be expected to impact microbial and host
cells in its capacity as a gasotransmitter (71).
Might sulfide be a viable disease biomarker and potential
diagnostic tool for patients living with CF? Sulfide has been
used as a disease biomarker and is considered a potential diag-
nostic tool in other clinical settings. As a gasotransmitter, sul-
fide participates in regulating the inflammatory response (72)
by being a proinflammatory signal or an anti-inflammatory
signal, depending on the situation (73). Although the role of
sulfide in the inflammatory response is complex and not en-
tirely understood, it has been shown to be a critical mediator in
chronic obstructive pulmonary disease (COPD). Levels of H2S
were increased as COPD progressed and became more severe
(74). Consistent with this trend, a previous study of CF patients
measured carbonyl sulfide, dimethylsulfide, and carbon disul-
fide concentrations in exhaled breath; higher concentrations of
carbonyl sulfide correlated with poorer lung function (75).
However, sulfide levels were not measured in this study and the
source of the exhaled sulfur compounds was unclear. Interest-
ingly, in asthma and pulmonary fibrosis, sulfide has been found
to have a countercorrelation, with healthier patients having
higher levels of sulfide in serum and breath (76–78). More
research is needed to determine whether any statistically sig-
nificant correlation exists between breath sulfide and lung
function in CF, although we did observe a statistically signifi-
cant negative correlation between sulfide presence and inpa-
tient status, suggesting that sulfide could be a biomarker of
good health in CF. The observed negative correlations between
sulfide abundance and patients needing supplemental oxygen
or patients being hospitalized also support this idea.
In summary, this study has revealed significant spatial and
temporal heterogeneity in major inorganic parameters that
characterize CF sputum both within and between patients.
These chemical dynamics likely reflect physiological adapta-
tions with a metabolically versatile microbial community that
TABLE 3 Net reactions of metabolisms likely to be important in sputum with sensitivity to pH and metabolic pathway modeling and pH influencea
Metabolic pathway Reaction
	G°=
(kJ/mol lactate)
	E°=
(mV)
	G (pH 4)
(kJ/mol lactate)
	E
(pH 4)
(mV)
Relative effect of low
pH
Reaction
context in
sputum
Aerobic respiration C3H5O3  3O2H¡ 3CO2 3H2O 1337 1160 1354 1170 1.3% more energetic 22
Denitrification 5C3H5O3  12NO3  17H¡ 15CO2
 6N2 21H2O
1262 1090 1320 1140 4.6% more energetic 14, 31, 35
Fumarate reduction 6 C4H2O42  C3H5O3  3H2OH
¡ 6 C4H4O42  3CO2
432 370 449 390 4% more energetic 31
Sulfate reduction 3SO422 C3H5O38 H¡ 3H2S
6CO2 7H2O
139 120 207 180 47% more energetic 31
Acetoclastic
methanogenesis
C2H3O2 H¡ CH4 CO2 37b 48 54b 70 31% more energetic 90
Hydrogenotrophic
methanogenesis
CO2 4 H2¡ CH4 2 H2O 33b 170 33b 170 No effect 90
Acetogenesis 2CO2 4 H2¡ C2H3O2 H  2H2O 24b 123 19b 101 20% less energetic 91
a Standard reduction potential differences (	Eo=) and standard Gibbs free energies (	Go=) were derived from reduction/oxidation half-reactions (51, 89) and calculated at standard
temperature (25°C) and pressure (1 atm) at pH 7, indicated by prime notation.
b 	G values for the reactions are per mole H2 and per mole acetate.
Cowley et al.
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are responsible, in part, for the generation of compounds that
impact the redox state of the sputum environment. Heightened
awareness of the extent of sputum anoxia, low pH, and the
potential for a fluctuating redox state can inform future re-
search into the survival mechanisms that pathogens utilize un-
der these conditions. From a point-of-care standpoint, it is
worth considering whether different chemical fingerprints
from sputum might improve the ability of clinicians to diag-
nose the extent of lung disease. Determining whether particu-
lar metabolic fingerprints correlate with disease progression
and, if so, which treatments would be most effective under
these conditions should be a priority for future work.
MATERIALS AND METHODS
Collection technique. Cystic fibrosis patients from Children’s Hospital
Los Angeles were recruited for this study, with the criteria of the patients
being at least 4 years old and having a positive CF diagnosis and the ability
to expectorate sputum. Patient consent and assent were obtained in ac-
cordance with Institutional Review Board (IRB) no. CCI-13000211. Spu-
tum samples were collected from patients upon expectoration.
Chart review. A review of the patients’ medical records from January
2012 to November 2014 was performed to obtain a variety of clinical
parameters, including age, gender, reason for hospital visit, height,
weight, BMI, and pulmonary lung function (see Table S1 in the supple-
mental material).
Microelectrode profiling. After collection, sputum samples were im-
mediately transferred to 3-ml cylindrical cavities molded into 20 ml of
agar in a truncated 50-ml Falcon tube. The tubes were placed in a heating
block tomaintain a constant temperature of 37°Cprior to and throughout
any measurements.
Six different microsensors were used throughout this study: an O2
microsensor with a tip diameter of 25 m, a STOX sensor with a tip
diameter of 50m, an N2Omicrosensor with a tip diameter of 25m, an
H2S microsensor with a tip diameter of 50 m, a pH microsensor with a
tip diameter of 25m, and a redox electrode with a tip diameter of 50m
in tandem with an Ag/AgCl needle reference electrode.
The O2, N2O, andH2Smicrosensors are all amperometric sensors and
were connected to picoampere amplifiers in a multimeter (Unisense,
Denmark). The redox and pH electrodes were both connected to high-
impedance millivoltmeter inputs in the same multimeter.
The O2 is a Clark-type amperometric electrode with a detection limit
of 0.30 M. The O2 sensor responds linearly to changes in oxygen con-
centration; thus, a two-point calibrationwas performed by immersing the
sensor tip in an oxygen-free solution made of sodium hydroxide and
sodium ascorbate (both at a final concentration of 0.1 M) to obtain the
zero-oxygen reading and in a 100%-air-saturated 0.72% salt solution,
which corresponds to 209.3 M oxygen at the given temperature and
salinity level (79). The switchable trace oxygen (STOX) sensor is a specific
measuring unit for detecting trace amounts of oxygen with a reported
detection limit of 2 nM. The design of the STOX sensor was also based on
an amperometric oxygen sensor but was modified by adding a second
cathode, which can be switched on and off via a controller unit that is
connected between the sensor and the multimeter. This second cathode,
or front guard, consumes any traces of oxygen that might enter the elec-
trode, thus enabling reliablemeasurements of ultralow oxygen concentra-
tions (80).
The H2S sensor was similarly linearly calibrated, with the zero point
being taken in a 0.72% salt solution and the second point by immersing
the sensor in a 100 M H2S solution prepared in an alkaline buffer solu-
tion thatwas kept anoxic by adding a reductant [Ti(III)Cl]. The sensor has
a detection limit of 0.30 M (33).
TheN2O sensor is also a Clark-type electrode, with a detection limit of
0.50 M. The sensor is equipped with an oxygen front guard to prevent
interference with the N2O measurement (81). The N2O sensor was lin-
early calibrated with the zero-point measurement taken in an N2O-free
0.72% salt solution; subsequently, a specified volume of N2O-saturated
Millipore water was added to reach a concentration of 66 M N2O for a
second calibration point.
The pH electrode was calibrated with buffers of pH 4, 7, and 10 (82).
The electrode has a detection limit of 0.1 pHunit. The redox electrodewas
used together with an Ag/AgCl reference electrode to establish the redox
potential, and the values are given relative to the standard hydrogen elec-
trode (SHE) andwere determined bymeasuring the offset of the reference
electrode in saturated quinhydrone buffer solutions (pH 4 and pH 7) with
known redox potentials. The electrode has a detection limit of 0.10 mV
(83). All calibrations were done at the experimental temperature of 37°C
and at 0.72% salinity.Microsensors weremounted on amotorizedmicro-
manipulator in a custom-made probe holder, allowing three sensors to be
used simultaneously. The reference electrode for redox and pHmeasure-
ments wasmounted separately in a free-standing ring stand and remained
in one place in the sample throughout the measurements that was not
controlled by the motorized micromanipulator. All microsensors and re-
lated equipment were purchased from Unisense A/S, Århus, Denmark.
In sets of three, sensors were positioned exactly at the air-sputum
interface (“depth zero”) by visual inspection using a Leica MZ 9.5 stereo-
microscope. Automatic profiling and data acquisition were controlled
using SensorTrace Pro 3.1.3 software. Vertical profiles were measured in
intervals of 50 or 150m through the sputum samples. At each depth, the
measuring time was set at 3 s with 2 s between measuring points for all
sensors. The time interval between adjacent profiles in the same sample
was 60 s. The profiles extended into the agar and began at least 250 m
above the surface of the sputum to determine the boundaries of the spu-
tum sample easily. All samples were profiled, and the sensor was never
positioned at a specific spot to log the concentration over time; rather, for
data logging of maxima over time, multiple profiles were determined and
themaximum concentration from each individual profile was plotted as a
function of time since expectoration.
After profile completion, samples were removed from the agar plugs,
added to a sterile tube, flash frozen in liquid nitrogen, and stored at
80°C. Time until freezing varied depending on the time course of the
profiles recorded and ranged from 30 min to 25 h.
Ion chromatography.Anion and cation concentrations in the sputum
samples were determined using a Dionex ICS-2000 ion chromatography
system with AS-19 and CS-12A columns, allowing simultaneous mea-
surement of anions and cations during one sample run. Sputum samples
were thawed and centrifuged at 5,000 rpm for 10 min. The supernatant
was filtered on a 0.20-m-pore-size filter at 10,000 rpm for 20 min. Fil-
tered sputum supernatants were diluted in a 1:50 ratio with Millipore
water before analysis.
Clinical correlations. Correlations were calculated in R using Spear-
man rank analysis. Statistical significance was evaluated using the P value
of the test statistic, with common thresholds used to group significance
levels (0.01 highly significant; 0.05 significant).
Modeling. Formodeling oxygen concentrations inCFmucus, we con-
sidered three different key geometries as outlined in Fig. 1. The simplest
case (Fig. 1A) considers a completely blocked airway, which is approxi-
mated as a column of mucus that allows diffusional gradients in one
dimension (distance x along a line into the mucus column). In this sce-
nario, the Laplacian simplifies to 2 
2
x2
and equation 1 at the steady
state becomes the following:
DO2 ·
2[O2]
x2
 Q · a 0 (3a)
We used the following assumptions to inform the boundary condi-
tions for equation 3a, taking a conservative approach that places an upper,
maximal bound on the oxygen concentrations throughout the modeled
mucus. First, oxygen diffusion from the gaseous into the aqueous phase at
the air-mucus interface was assumed to be much faster than diffusion
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deeper into the mucus, which implies a constant oxygen maximumO2max
at x 0. Second, no oxygen gradient was assumed to develop across the
boundary at the maximum distance from the air-mucus interface xmax
(e.g., across the mucus-epithelial cell boundary). This equates to the fol-
lowing:
[O2](x 0) O2max
 [O2]
x |xxmax 0
The second scenario (Fig. 1B) describes an airway that is covered with
a mucus layer of variable thickness. Assuming oxygen in air to be
subject to very subtle gradients only when flowing through bronchi-
oles, the bronchioles can be idealized as long radially symmetric cyl-
inders with a homogenous mucus layer lining the inner wall of the
cylinder and oxygen diffusing outward into the mucus. This can be
described by expressing equation 1 in cylindrical coordinates with radius
r, angular coordinate 	, and height z, in which case the Laplacian equation
is2
2
r2

1
r

r

1
r2
2
	2

2
z2
. Approximating the bronchioles as an
infinite hollow cylinder without variation in [O2] along its length
O2
z
 0 and with radial symmetry O2
	
 0, equation 1 at the
steady state becomes the following:
DO2 ·  2 r2  1r  r [O2] Q · a 0 (3b)
Here, the same assumptions previously considered for the first sce-
nario translate to an oxygen maximum at the inner mucus boundary
(air-mucus interface) at distance r1 from the center of the bronchiole and
a reflecting boundary at outer radius r2 (with r2  1/2 the bronchiole
diameter and mucus thickness r2 r1):
[O2](r r1) O2max
 [O2]
 r |rr2 0
The third scenario we considered (Fig. 1C) is a dislodged mucus plug
that has a roughly spherical geometry, with oxygen diffusing inward
from the surface at radius rplug into the center of the plug (r 0). This can
be described by expressing equation 1 in spherical coordinates with radius
r, polar angle 	, and azimuthal angle 
, in which case the Laplacian equa-
tion is 2 
2
r2

2
r

r

1
r2
2
	2

1
r2
cos	
sin	

	

1
r2sin2	
2

2
. Assum-
ing radial and azimuthal symmetry in the oxygen concentrations
O2
	
 0;
O2


 0, equation 1 at the steady state becomes the
following:
DO2 ·  2 r2  2r  r[O2] Q · a 0 (3c)
with reverse boundary conditions
[O2](r rplug) O2max
 [O2]
 r |r0 0
Finally, the expression for respiration rate Q (equation 2) can be sub-
stituted into equations 3a, b, and c to relate the diffusivity parameters to
the physiological microbial constraints, with the whole expression nondi-
mensionalized (38) to extract scaling parameters that intuitively relate the
physical and physiological parameters to each other and simplify model-
ing. For modeling purposes, all spatial scales and concentrations are non-
dimensionalized using the following scaling factors (and introducing
maintenance parameter g):
{r*, x*} {r, x} · 1
DO2
·
max · a
kO2 · YO2
[O2
*]
[O2]
kO2
g 
YO2 · PO2
max
This yields the following nondimensionalized equations for the differ-
ent geometric scenarios:
C : DO2 ·
2[O2]
x2
 max
YO2
·
[O2]
kO2 [O2]
 PO2 · a 0
2[O2
*]
x2
  [O2*]
1 [O2
*]
 g 0
and, similarly,
B: 2[O2*]
 r*2

1
r*
 [O2
*]
 r*
  [O2*]
1 [O2
*]
 g 0
A: 2[O2*]
 r*2

2
r*
 [O2
*]
 r*
  [O2*]
1 [O2
*]
 g 0
The parameters used to compute the scaling factors for the modeling
(Table 2) are based on literature values compiled by various studies, with
physiological parameters primarily derived from the compilation for
P. aeruginosa by Kempes et al. (38). The main parameters adjusted in this
study were the spatial scales (mucus thickness) and cell density, with ad-
ditional oxygen diffusivity results presented in Fig. S3 in the supplemental
material.
Diffusion was modeled in R using the ReacTran package (84), and
steady-state concentrations were computed using the rootSolve package
(85). A complete, documented copy of all scripts required to reproduce
the modeling results and model fitting to collected data can be found in
Text S1 and S2 in the supplemental material, where a link is provided to
access this online information (hosted on Github).
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